Boeing Case Highlights Risk For Health, Life Sciences Boards

By Paul Kalb and Holly Gregory (September 29, 2021, 6:16 PM EDT) -- On Sept. 7, the Delaware Chancery Court allowed In re: The Boeing Co. Derivative Litigation to proceed, surviving a motion to dismiss.[1]

The action alleges that directors breached their fiduciary duties with respect to their oversight of safety issues and arises out of two crashes of the company's 737 MAX aircraft.

This decision is the latest in a recent set of cases in which the Delaware courts have allowed so-called Caremark claims to proceed past the motion-to-dismiss stage.[2] In these cases, the courts have made clear that directors must be particularly attentive to oversight of mission-critical regulatory or safety-related risks....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!